Matches in Nanopublications for { ?s ?p "[To determine whether polymorphisms at IL4/IL9 or IFNGR1 contribute to susceptibility, we examined 59 multicase families of visceral leishmaniasis (VL) with/without post Kala-azar dermal leishmaniasis (PKDL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP686354.RAc5O2FIxN-yxSLJ0GGJfRx1JTdeCks5YLblkSj9jeuqs130_assertion description "[To determine whether polymorphisms at IL4/IL9 or IFNGR1 contribute to susceptibility, we examined 59 multicase families of visceral leishmaniasis (VL) with/without post Kala-azar dermal leishmaniasis (PKDL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP686354.RAc5O2FIxN-yxSLJ0GGJfRx1JTdeCks5YLblkSj9jeuqs130_provenance.
- NP808117.RA3wktLK2AfchT_qDF-8-Hu066Xk3s9ULQkxOiHwn7TbA130_assertion description "[To determine whether polymorphisms at IL4/IL9 or IFNGR1 contribute to susceptibility, we examined 59 multicase families of visceral leishmaniasis (VL) with/without post Kala-azar dermal leishmaniasis (PKDL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP808117.RA3wktLK2AfchT_qDF-8-Hu066Xk3s9ULQkxOiHwn7TbA130_provenance.
- NP495210.RASCifrtSDtp5uCrYBnFWRTqSmKaSxjCx_pWCjd6xPT8w130_assertion description "[To determine whether polymorphisms at IL4/IL9 or IFNGR1 contribute to susceptibility, we examined 59 multicase families of visceral leishmaniasis (VL) with/without post Kala-azar dermal leishmaniasis (PKDL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP495210.RASCifrtSDtp5uCrYBnFWRTqSmKaSxjCx_pWCjd6xPT8w130_provenance.
- NP401037.RA296E7EKPjdvRw3HnSOXKA_RAGtLA-9ccuj34KZErVy8130_assertion description "[To determine whether polymorphisms at IL4/IL9 or IFNGR1 contribute to susceptibility, we examined 59 multicase families of visceral leishmaniasis (VL) with/without post Kala-azar dermal leishmaniasis (PKDL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP401037.RA296E7EKPjdvRw3HnSOXKA_RAGtLA-9ccuj34KZErVy8130_provenance.
- NP401036.RAOB6BqyzlGt1LT4k1Iuerg7Cqm_5-iMzZHOf-NF8QNG4130_assertion description "[To determine whether polymorphisms at IL4/IL9 or IFNGR1 contribute to susceptibility, we examined 59 multicase families of visceral leishmaniasis (VL) with/without post Kala-azar dermal leishmaniasis (PKDL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP401036.RAOB6BqyzlGt1LT4k1Iuerg7Cqm_5-iMzZHOf-NF8QNG4130_provenance.
- NP502543.RAsz9SYvSLS6_LE1-RRA-mTXGX12FzD31RDI5-8e06ytI130_assertion description "[To determine whether polymorphisms at IL4/IL9 or IFNGR1 contribute to susceptibility, we examined 59 multicase families of visceral leishmaniasis (VL) with/without post Kala-azar dermal leishmaniasis (PKDL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502543.RAsz9SYvSLS6_LE1-RRA-mTXGX12FzD31RDI5-8e06ytI130_provenance.